Addicted

GLP-1 drugs like Ozempic, originally developed for diabetes and later weight loss, are now being tested in clinical trials for a widening range of conditions, including heart failure, addiction and even aspects of aging. The story highlights how quickly these medications are moving beyond their original use, with researchers exploring new therapeutic applications and observers debating how far the trend may go.

Golfer Phil Mickelson has entered rehab, saying he is being treated for what he described as family trauma and addiction. The announcement has drawn broad attention in the sports world, with fans and commentators reacting to the six-time major champion's decision to step away and address personal issues openly.